If you or your doctor believe your child might have an inherited form of cancer or be at increased risk for developing cancer – or if you are considering having children and want to better understand possible risk for your children – you may wish to schedule
an appointment with us.
Our program is recommended for children who have:
- A diagnosis or prior treatment for a rare childhood cancer or brain tumor
- A diagnosis or prior treatment for a cancer of any type plus a family history of cancer
- A strong family history of cancer
- A parent (or another relative) known to have a cancer syndrome or a cancer gene mutation
The field of genetics is rapidly changing, and we provide advanced options in genetic testing across the spectrum of new and established inherited cancer syndromes. The syndromes include, but are not limited to:
- DICER1 syndrome
- Hereditary retinoblastoma
- Li-Fraumeni syndrome
- Multiple Endocrine Neoplasia
- Pheochromocytoma/paraganglioma syndrome
- Von Hippel-Lindau syndrome
- PTEN Hamartoma Syndrome — including Cowden Syndrome
- Polyposis Syndromes — including Familial Adenomatous Polyposis, Juvenile Polyposis
- Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)
- Familial Neuroblastoma (ALK)
- Congenital Central Hypoventilation Syndrome
- Congenital Mismatch Repair Deficiency (CMMRD) or Biallelic Mismatch Repair Deficiency (BMMRD)
- Gorlin Syndrome
- Rhabdoid Tumor Predisposition Syndrome
Although our Pediatric Cancer Genetic Risk Program is focused on pediatric cancer risk, adult family members may choose to visit the Dana-Farber Center for Cancer Genetics and Prevention.
Both programs work closely together, allowing us to provide integrated care for families.